Watson biology: the net profit in 2021 is expected to decrease by 54% - 64% year-on-year
Watson biology announced that in 2021, the company's pre profit was 365 million yuan – 460 million yuan, a year-on-year decrease of 54% - 64%. The company increased its R & D investment in new products and projects, actively promoted domestic and foreign clinical trials of key R & D projects, and the R & D expenses increased by about 256% over the same period of last year.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Watson biology: 13 valent pneumococcal polysaccharide conjugate vaccine has been licensed in Morocco
Apr 25, 2022 01:02 PM
Research
Consumer StaplesChina’s Food and Beverage Industry in Search of Methods to Shrink its Carbon Footprints
Apr 19, 2022 11:38 PM
Apr 18, 2022 06:30 PM
Jun 29, 2021 11:48 PM
Briefing Dec 12, 2021 05:48 PM
· Healthcare
Watson biology: Yuxi Watson plans to invest in the production and capacity expansion project of polysaccharide conjugate vaccine, with a total investment of 695 million yuan
Insight
Automotive, Technology, Consumer Staples
Prelude to ESG 2022: The Third Generation of Chinese Entrepreneurs Is Taking the World
The new generation of global entrepreneurs are stepping up to the center of the world entrepreneur stage and becoming more active as China opens increasingly up. In the meantime, China is attracting attention from international entrepreneurs and innovators since its market place and manufacturing capability have become essential links to international entrepreneurship and innovation.
Aug 08, 2022 06:00 PM
Healthcare
IVD Company Health Genetech Bags Hundreds of Mns of CNY in Series C Round
Founded in 2011, Health Genetech, a medical test solution provider, focuses on clinical diagnosis and forensic science. It provides comprehensive medical test solutions covering molecular diagnosis, immuno-diagnosis and biochemical diagnosis for medical institutions and local disease control authorities as well as DNA-based human identification and kinship identification for public security and judicial institutions.
Aug 08, 2022 03:47 PM
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
In-depth
Healthcare
WIM 2022: Transcript of Fireside Chat of Biotech [1/2]
EqualOcean organized the WIM2022 event in New York City from July 29 to July 30, 2022. The following is the transcript for Fireside Chat of Biotech. Leon Tang, Bing Yuan, Ying Huang, Dahai Guo, and Sally Wang are the five guest speakers in this chat.
Aug 05, 2022 09:11 PM
In-depth
Healthcare
WIM 2022: Transcript of Fireside Chat of Biotech [2/2]
EqualOcean organized the WIM2022 event in New York City from July 29 to July 30, 2022. The following is the transcript for Fireside Chat of Biotech. Leon Tang, Bing Yuan, Ying Huang, Dahai Guo, and Sally Wang are the five guest speakers in this chat.
Aug 05, 2022 09:08 PM
Briefing Jul 29, 2021 10:01 AM
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth